BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26983703)

  • 1. Convenient Preparation of [(68)Ga]DKFZ-PSMA-11 Using a Robust Single-Vial Kit and Demonstration of Its Clinical Efficacy.
    Satpati D; Shinto A; Kamaleshwaran KK; Sane S; Banerjee S
    Mol Imaging Biol; 2016 Jun; 18(3):420-7. PubMed ID: 26983703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients.
    Ebenhan T; Vorster M; Marjanovic-Painter B; Wagener J; Suthiram J; Modiselle M; Mokaleng B; Zeevaart JR; Sathekge M
    Molecules; 2015 Aug; 20(8):14860-78. PubMed ID: 26287143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of
    Guleria M; Amirdhanayagam J; Sarma HD; Rallapeta RP; Krishnamohan VS; Nimmagadda A; Ravi P; Patri S; Kalawat T; Das T
    Biomed Res Int; 2021; 2021():1555712. PubMed ID: 34845436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kit-based preparation of [
    Hong H; Wang G; Ploessl K; Zha Z; Zang J; Zhu Z; Zhu L; Kung HF
    Nucl Med Biol; 2022; 106-107():1-9. PubMed ID: 34952347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
    Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
    Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convenient Formulation of
    Guleria M; Das T; Amirdhanayagam J; Shinto AS; Kamaleshwaran KK; Pandian A; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2019 Mar; 34(2):67-75. PubMed ID: 30394799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSA-stratified detection rates for [
    Derlin T; Schmuck S; Juhl C; Zörgiebel J; Schneefeld SM; Walte ACA; Hueper K; von Klot CA; Henkenberens C; Christiansen H; Thackeray JT; Ross TL; Bengel FM
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):913-922. PubMed ID: 29308527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single vial cold kits optimized for preparation of gastrin releasing peptide receptor (GRPR)-radioantagonist
    Vats K; Sharma R; Kameswaran M; Satpati D; Dash A
    J Pharm Biomed Anal; 2019 Jan; 163():39-44. PubMed ID: 30278325
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeatability of [
    Osborne JR; Kalidindi TM; Punzalan BJ; Gangangari K; Spratt DE; Weber WA; Larson SM; Pillarsetty NVK
    Mol Imaging Biol; 2017 Dec; 19(6):944-951. PubMed ID: 28534214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Predictive Factors, and Prediction Nomograms for
    Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M
    Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of
    Albisinni S; Artigas C; Aoun F; Biaou I; Grosman J; Gil T; Hawaux E; Limani K; Otte FX; Peltier A; Sideris S; Sirtaine N; Flamen P; van Velthoven R
    BJU Int; 2017 Aug; 120(2):197-203. PubMed ID: 27981732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiochemistry and Preclinical PET Imaging of
    Gourni E; Del Pozzo L; Bartholomä M; Kiefer Y; T Meyer P; Maecke HR; Holland JP
    Mol Imaging; 2017; 16():1536012117737010. PubMed ID: 29098927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.
    Banerjee SR; Pullambhatla M; Byun Y; Nimmagadda S; Green G; Fox JJ; Horti A; Mease RC; Pomper MG
    J Med Chem; 2010 Jul; 53(14):5333-41. PubMed ID: 20568777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-labeled PSMA-11 (68Ga-isoPROtrace-11) synthesized with ready to use kit: normal biodistribution and uptake characteristics of tumour lesions.
    Kurash MM; Gill R; Khairulin M; Harbosh H; Keidar Z
    Sci Rep; 2020 Feb; 10(1):3109. PubMed ID: 32080309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of
    Wang Y; Shao G; Wu J; Cui C; Zang S; Qiu F; Jia R; Wang Z; Wang F
    Contrast Media Mol Imaging; 2018; 2018():8046541. PubMed ID: 29853810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
    Ray Banerjee S; Chen Z; Pullambhatla M; Lisok A; Chen J; Mease RC; Pomper MG
    Bioconjug Chem; 2016 Jun; 27(6):1447-55. PubMed ID: 27076393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of
    Bailey J; Piert M
    Curr Urol Rep; 2017 Sep; 18(11):84. PubMed ID: 28889366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of
    Gauthé M; Belissant O; Girard A; Zhang Yin J; Ohnona J; Cottereau AS; Nataf V; Balogova S; Pontvert D; Lebret T; Guillonneau B; Cussenot O; Talbot JN
    Prog Urol; 2017; 27(8-9):474-481. PubMed ID: 28576423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.